243 related articles for article (PubMed ID: 33691379)
41. Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.
Inoue D; Polaski JT; Taylor J; Castel P; Chen S; Kobayashi S; Hogg SJ; Hayashi Y; Pineda JMB; El Marabti E; Erickson C; Knorr K; Fukumoto M; Yamazaki H; Tanaka A; Fukui C; Lu SX; Durham BH; Liu B; Wang E; Mehta S; Zakheim D; Garippa R; Penson A; Chew GL; McCormick F; Bradley RK; Abdel-Wahab O
Nat Genet; 2021 May; 53(5):707-718. PubMed ID: 33846634
[TBL] [Abstract][Full Text] [Related]
42. The abundance of the spliceosomal snRNPs is not limiting the splicing of U12-type introns.
Pessa HK; Ruokolainen A; Frilander MJ
RNA; 2006 Oct; 12(10):1883-92. PubMed ID: 16957280
[TBL] [Abstract][Full Text] [Related]
43. The Arabidopsis homolog of human minor spliceosomal protein U11-48K plays a crucial role in U12 intron splicing and plant development.
Xu T; Kim BM; Kwak KJ; Jung HJ; Kang H
J Exp Bot; 2016 May; 67(11):3397-406. PubMed ID: 27091878
[TBL] [Abstract][Full Text] [Related]
44. The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Boultwood J; Dolatshad H; Varanasi SS; Yip BH; Pellagatti A
Adv Biol Regul; 2014 Jan; 54():153-61. PubMed ID: 24080589
[TBL] [Abstract][Full Text] [Related]
45. Genomic mRNA profiling reveals compensatory mechanisms for the requirement of the essential splicing factor U2AF.
Sridharan V; Heimiller J; Singh R
Mol Cell Biol; 2011 Feb; 31(4):652-61. PubMed ID: 21149581
[TBL] [Abstract][Full Text] [Related]
46. Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes.
Yip BH; Dolatshad H; Roy S; Pellagatti A; Boultwood J
Curr Pharm Des; 2016; 22(16):2333-44. PubMed ID: 26916023
[TBL] [Abstract][Full Text] [Related]
47. Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome.
Shirai CL; White BS; Tripathi M; Tapia R; Ley JN; Ndonwi M; Kim S; Shao J; Carver A; Saez B; Fulton RS; Fronick C; O'Laughlin M; Lagisetti C; Webb TR; Graubert TA; Walter MJ
Nat Commun; 2017 Jan; 8():14060. PubMed ID: 28067246
[TBL] [Abstract][Full Text] [Related]
48. Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches.
Armstrong RN; Steeples V; Singh S; Sanchi A; Boultwood J; Pellagatti A
Adv Biol Regul; 2018 Jan; 67():13-29. PubMed ID: 28986033
[TBL] [Abstract][Full Text] [Related]
49. Intron splicing: U12 spliceosomal introns not so 'minor' after all.
Fast NM
Curr Biol; 2021 Jul; 31(14):R912-R914. PubMed ID: 34314721
[TBL] [Abstract][Full Text] [Related]
50. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations.
Pellagatti A; Armstrong RN; Steeples V; Sharma E; Repapi E; Singh S; Sanchi A; Radujkovic A; Horn P; Dolatshad H; Roy S; Broxholme J; Lockstone H; Taylor S; Giagounidis A; Vyas P; Schuh A; Hamblin A; Papaemmanuil E; Killick S; Malcovati L; Hennrich ML; Gavin AC; Ho AD; Luft T; Hellström-Lindberg E; Cazzola M; Smith CWJ; Smith S; Boultwood J
Blood; 2018 Sep; 132(12):1225-1240. PubMed ID: 29930011
[No Abstract] [Full Text] [Related]
51. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
[TBL] [Abstract][Full Text] [Related]
52. Splicing of a rare class of introns by the U12-dependent spliceosome.
Will CL; Lührmann R
Biol Chem; 2005 Aug; 386(8):713-24. PubMed ID: 16201866
[TBL] [Abstract][Full Text] [Related]
53. U12-dependent intron splicing in plants.
Simpson CG; Brown JW
Curr Top Microbiol Immunol; 2008; 326():61-82. PubMed ID: 18630747
[TBL] [Abstract][Full Text] [Related]
54. Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
Aslan D; Garde C; Nygaard MK; Helbo AS; Dimopoulos K; Hansen JW; Severinsen MT; Treppendahl MB; Sjø LD; Grønbæk K; Kristensen LS
Oncotarget; 2016 Mar; 7(9):9951-63. PubMed ID: 26848861
[TBL] [Abstract][Full Text] [Related]
55. A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.
Janusz K; Del Rey M; Abáigar M; Collado R; Ivars D; Hernández-Sánchez M; Valiente A; Robledo C; Benito R; Díez-Campelo M; Ramos F; Kohlmann A; Cañizo CD; Hernández-Rivas JM
Leuk Res; 2017 May; 56():82-87. PubMed ID: 28222336
[TBL] [Abstract][Full Text] [Related]
56. U12 type introns were lost at multiple occasions during evolution.
Bartschat S; Samuelsson T
BMC Genomics; 2010 Feb; 11():106. PubMed ID: 20149226
[TBL] [Abstract][Full Text] [Related]
57. The molecular pathogenesis of the myelodysplastic syndromes.
Pellagatti A; Boultwood J
Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
[TBL] [Abstract][Full Text] [Related]
58. Evolutionary dynamics of U12-type spliceosomal introns.
Lin CF; Mount SM; Jarmołowski A; Makałowski W
BMC Evol Biol; 2010 Feb; 10():47. PubMed ID: 20163699
[TBL] [Abstract][Full Text] [Related]
59. Physiological
Kon A; Yamazaki S; Nannya Y; Kataoka K; Ota Y; Nakagawa MM; Yoshida K; Shiozawa Y; Morita M; Yoshizato T; Sanada M; Nakayama M; Koseki H; Nakauchi H; Ogawa S
Blood; 2018 Feb; 131(6):621-635. PubMed ID: 29146882
[TBL] [Abstract][Full Text] [Related]
60. Mutational analysis of the U12-dependent branch site consensus sequence.
Brock JE; Dietrich RC; Padgett RA
RNA; 2008 Nov; 14(11):2430-9. PubMed ID: 18824513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
